Digital Health Global

MARCH 16, 2023

The seed round was co-led by Wellington Partners and Forbion and includes non-dilutive financing from BMBF GO-Bio, a prestigious German government initiative aimed at supporting the most innovative startups in the life sciences. Forbion invests in life sciences companies that are active in the (bio) pharmaceutical space.

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science 99

Life Science Drug Development Digital Health Health IT 99

Digital Health Global

NOVEMBER 20, 2023

With long-term backing from AstraZeneca and strategic collaborations with Parexel and Fortrea, Evinova offers globally-scaled digital products and services to the life sciences and healthcare sector. However, they are vital to the drug development and approval process and critical in enabling access to innovative medicines.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals 64

Pharmaceuticals Digital Health Drug Development Life Science 64

Healthcare IT Today

JANUARY 23, 2024

It can test thousands of protocol variations and discover the optimal trial design for success, helping research and development (R&D) teams more accurately and rapidly predict clinical trial results and decide whether a trial should proceed, how to optimize cohorts, whether drugs can be repurposed, and other crucial factors.

Drug Development 108

Drug Development Pharmaceuticals Life Science BioTech 108

Healthcare IT Today

JANUARY 17, 2024

The coming year will see exploration of how to apply the technology, but we will not yet see a full integration of generative AI within labeling. Automation in the form of generative artificial intelligence within labeling is highly anticipated, but it will take time to build confidence in the technology.

Health IT 125

Health IT Mental health Interoperability Patient Experience 125